ASTRO-BCRF Career Development Award to End Breast Cancer
Applications for the 2020 ASTRO-BCRF Career Development Award to End Breast Cancer are now open! Applications must be submitted through Proposal Central.
Applications are due on February 15, 2020.
What is the goal of the ASTRO-BCRF Career Development Award?
To advance the field of radiation oncology in novel ways through the support of talented early-career scientists performing radiation oncology-related research. The aim of the CDA is to support the next generation of researchers and to significantly improve outcomes and quality of life for breast cancer patients.
The award will provide up to $100,000 per year for two years. Neither ASTRO nor BCRF will pay indirect costs as part of this award. One award will be funded. Research must be focused on understanding or treatment of breast cancer and include use or impact of radiation treatment.
Am I eligible?
You are eligible if:
- You are an investigator employed by a recognized U.S. research institution (PhD, MD or MD/PhD) with no more than five years in a faculty appointment at the time of application, and an ASTRO member in good standing.
- Investigators must designate a mentor, preferably one at the same institution, who will provide guidance and support. Mentors should be senior investigators with a minimum of R01 or equivalent level funding and provide a letter of support detailing their oversight and support.
- Successful applicants must attend at least one ASTRO Annual Meeting and the BCRF Research Meeting and present the findings of this research study at both meetings.
- Other eligibility requirements as listed in the full RFA.
Your institutions's responsibilities:
- A written letter from the institution detailing a commitment to the development of the applicant as a productive, independent investigator, as well as intent for 50 percent of the recipient’s full time professional effort to be devoted to research, will be required.
- The institution will be required to provide sufficient additional funds to supplement salaries or supplies as needed for the research.
- Other responsibilities as listed in the full RFA.
What are the terms of the award?
One junior faculty is selected annually for this award, which provides $100,000 each year for two years.
At least 50% of the recipient’s full-time professional effort must be devoted to research. The remainder may be devoted to clinical, teaching or other pursuits.
How do I apply?
The applications will be accepted through ProposalCentral's online submission service. Paper applications are not accepted. For more detailed guidelines see the full RFA.
When is the application deadline?
Applications are due February 15, 2020.
When does the award begin?
The start date for 2020 award is July 1, 2020, and the award will run through June 30, 2022. For any questions please email the Scientific Affairs Department.
What if I don't complete my work within two years?
ASTRO allows for no-cost extensions on a case-by-case basis. Requests for no-cost extensions must be submitted to ASTRO's Scientific Affairs division.
Previous Junior Faculty Awardees and Abstracts
Metabolic reprogramming mediates radiation-induced dedifferentiation of breast cancer cells into cancer stem cells
Squamous Cell Carcinoma Antigen in Cervical Cancer and Radiation Resistance
Genomic determinants of chemoradiotherapy in anal cancer
Radiotherapy for Chemoresistant TNBC
Ketogenic diets and EGFR inhibitors as lung cancer therapy
Impact of macrophage polarization on radiation therapy efficacy
Autophagy Inhibition in Pancreatic Cancer
MEK1/2 inhibitors in K-Ras mutant cancers